CRMD

CRMD R&D Expenses

$27.59MTTM · USD

Period ending:

CRMD FY R&D ExpensesUSD
CRMD FY R&D Expenses2008-12-31: $3.08M2009-12-31: $4.89M2010-12-31: $5.49M2011-12-31: $4.10M2012-12-31: $1.19M2013-12-31: $1.23M2014-12-31: $1.32M2015-12-31: $6.28M2016-12-31: $15.74M2017-12-31: $24.49M2018-12-31: $18.82M2019-12-31: $11.05M2020-12-31: $13.38M2021-12-31: $13.13M2022-12-31: $10.68M2023-12-31: $13.16M2024-12-31: $3.94M2025-12-31: $19.33M$24.49M$0.00
2008-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CRMD r&d expenses history

Research and development spending. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.

Cormedix Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
19,333,000
3,942,270
13,155,125
10,679,549
13,132,982
13,377,193
11,052,903
18,822,488
24,486,122
15,735,300
6,281,823
1,318,734
1,226,874
1,187,631
4,098,225
5,494,297
4,888,538
3,083,002

Compare r&d expenses

All CRMD financial metrics · CRMD stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.